Air Liquide Japan agreed on joint sales promotion for hand disinfection products

  • Press Releases

Air Liquide Japan Ltd. has agreed with Kyorin Pharmaceutical Company, Limited (head-office: Chiyoda-Ku, Tokyo, President: Mitsutomo Miyashita), which is a subsidiary of Kyorin Holdings, Inc (head-office: Chiyoda-Ku, Tokyo, President: Minoru Hogawa) upon their partnership in sales promotion and supply for Air Liquide Japan’s hygiene product group, specialized in hand antisepsis. This partnership will become effective in around spring 2017.

The hand hygiene product group covered in this agreement include alcohol hand hygiene agents, named “Puremist®” and “Purerubbing®”, antimicrobial soap, “Microshield®”, hand soap and lotion, “Gentle Cleanser” and “Lotion Moisturizer,” which are used for infection control at hospitals and medical institutions. Since Schulke & Mayr GmbH, Air Liquide’s entity specialized in hygiene and nosocomial-infection-related products, acquired the Japanese business in December 2015, Air Liquide Japan has been engaged into the sales expansion of the products in Japan.

Kyorin Pharmaceutical Group has been devoted to its environmental hygiene business to contribute, via the control over environmental infection, to meeting the medical needs for health amid the growing importance on daily preventive control of infection at medical institutions in Japan. Entering into the partnership with Air Liquide Japan, Kyorin shall aim even further at expanding its product portfolio.

Serving also as a provider of medical gases, equipment and services in the healthcare field, Air Liquide Japan has firmly built its presence in healthcare field inside Japan. By utilizing the wide-ranging network of pharmaceutical and medical business operations developed by Kyorin, Air Liquide Japan shall further develop its support structure and sales network to respond quickly to its customer needs and thereby reinforce its business.

Shiro Yahara, President of Air Liquide Japan, commented, “Making the partnership with Kyorin Pharmaceutical Company and jointly marketing this product group, we are convinced that our Company will reach the market more broadly and deeply. To unequivocally demonstrate our policy, “Customer First,” we will improve further on our corporate and service structure to precisely meet customers’ demands in the healthcare field.”


CONTACTS

Air Liquide Japan Communications

Shun Toyoyama

03 6414 6728